<DOC>
	<DOCNO>NCT03034941</DOCNO>
	<brief_summary>The aim study evaluate impact short-term weight reduction achieve 12-week intervention metformin alone combination liraglutide oocyte maturity embryo quality infertile obese PCOS population .</brief_summary>
	<brief_title>Short Term Weight Loss With Liraglutide Metformin Infertile Obese PCOS Patients</brief_title>
	<detailed_description>Polycystic ovary syndrome ( PCOS ) common cause anovulatory infertility , particular PCOS link obesity . Obese PCOS poor IVF outcome associate impaired oocyte embryo parameter morphology . The purpose pilot prospective study investigate effect antiobesity medical therapy ( combination metformin liraglutide ( COMBI ) ) short time weight loss specific infertile obese PCOS population . Additionally , analyze eventual impact short term weight loss 5 % IVF oocyte maturity embryo quality infertile obese PCOS population .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>polycystic ovary syndrome ( rotterdam criterion ) BMI 30 kg/mÂ² high Infertility IVF normal male sperm type 1 type 2 diabetes mellitus history carcinoma Cushing 's syndrome congenital ( nonclassic ) adrenal hyperplasia personal family history multiple endocrine neoplasia 2 significant cardiovascular , kidney hepatic disease use medication know suspected affect reproductive metabolic function use statin , within 90 day prior study entry</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Obesity</keyword>
	<keyword>PCOS</keyword>
	<keyword>Infertility</keyword>
	<keyword>Liraglutide</keyword>
	<keyword>Metformin</keyword>
	<keyword>IVF</keyword>
</DOC>